Unfortunately, these studies did not examine the leptin–adiponectin ratio, which was analyzed in prostate cancer.Siemińska et al. and Di Sebastiano et al. reported that in the poorly differentiated cancer subgroup, patients had a higher leptin-to-adiponectin ratio [119,125]. The gene discussed is ADIPOQ; the disease is prostate cancer.